First Trust Advisors Portfolio holdings
AUM
$124B
This Quarter Return
+6.74%
1 Year Return
+23.24%
3 Year Return
+77.03%
5 Year Return
+144.93%
10 Year Return
+396.84%
AUM
$34B
AUM Growth
+$34B
(+15%)
Cap. Flow
+$3.42B
Cap. Flow
% of AUM
10.05%
Top 10 Holdings %
Top 10 Hldgs %
11.75%
Holding
2,404
New
161
Increased
1,023
Reduced
1,022
Closed
189
Top Buys
Top Sells
| 1 |
CBST
CUBIST PHARMACEUTICALS INC
CBST
|
$96.7M |
| 2 |
NPSP
NPS PHARMACEUTICALS INC
NPSP
|
$85M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$64.4M |
| 4 |
MJN
Mead Johnson Nutrition Company
MJN
|
$58.1M |
| 5 |
PepsiCo
PEP
|
$53.9M |
Sector Composition
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Technology | 10.37% |
| 4 | Consumer Staples | 8.42% |
| 5 | Communication Services | 6.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Illumina
ILMN
$15.8B
| $149M | 0.44% | 804,846 +192,620 | +31% | +$35.8M |
|
27
Kroger
KR
$44.9B
| $148M | 0.44% | 1,934,292 +74,583 | +4% | +$5.72M |
|
28
AT&T
T
$209B
| $148M | 0.43% | 4,531,908 -812,827 | -15% | -$26.5M |
|
29
Gilead Sciences
GILD
$140B
| $146M | 0.43% | 1,491,841 +85,660 | +6% | +$8.41M |
|
30
Pfizer
PFE
$141B
| $144M | 0.42% | 4,150,120 +285,974 | +7% | +$9.95M |
|
31
Biogen
BIIB
$19.4B
| $144M | 0.42% | 341,875 -41,881 | -11% | -$17.7M |
|
32
Salesforce
CRM
$245B
| $142M | 0.42% | 2,128,658 +264,108 | +14% | +$17.6M |
|
33
Intel
INTC
$107B
| $141M | 0.42% | 4,522,577 -248,981 | -5% | -$7.79M |
|
34
Constellation Brands
STZ
$28.5B
| $141M | 0.42% | 1,215,678 +77,469 | +7% | +$9M |
|
35
CVS Health
CVS
$92.8B
| $141M | 0.41% | 1,367,639 +253,273 | +23% | +$26.1M |
|
36
Celldex Therapeutics
CLDX
$1.47B
| $132M | 0.39% | +4,736,943 | New | +$132M |
|
37
Alnylam Pharmaceuticals
ALNY
$58.5B
| $131M | 0.38% | 1,254,525 +396,842 | +46% | +$41.4M |
|
|
WBA
38
DELISTED
Walgreens Boots Alliance
WBA
| $131M | 0.38% | 1,546,783 +608,528 | +65% | +$51.5M |
|
39
Alkermes
ALKS
$4.78B
| $129M | 0.38% | 2,119,760 +677,025 | +47% | +$41.3M |
|
40
Hain Celestial
HAIN
$162M
| $127M | 0.37% | 1,978,114 +79,241 | +4% | +$5.08M |
|
41
Chevron
CVX
$324B
| $126M | 0.37% | 1,199,627 +73,246 | +7% | +$7.69M |
|
|
RAD
42
DELISTED
Rite Aid Corporation
RAD
| $126M | 0.37% | 14,478,765 +14,369,677 | +13,173% | +$125M |
|
43
Apple
AAPL
$3.45T
| $120M | 0.35% | 960,526 -145,993 | -13% | -$18.2M |
|
44
Cencora
COR
$56.5B
| $119M | 0.35% | 1,045,168 +100,687 | +11% | +$11.4M |
|
45
Verizon
VZ
$186B
| $118M | 0.35% | 2,431,729 -183,643 | -7% | -$8.93M |
|
46
Netflix
NFLX
$513B
| $118M | 0.35% | 283,711 -36,942 | -12% | -$15.4M |
|
47
Myriad Genetics
MYGN
$593M
| $118M | 0.35% | 3,326,239 +449,817 | +16% | +$15.9M |
|
|
QGENF
48
DELISTED
QIAGEN NV
QGENF
| $118M | 0.35% | 4,662,868 +1,360,400 | +41% | +$34.3M |
|
49
Novavax
NVAX
$1.21B
| $117M | 0.34% | +14,118,033 | New | +$117M |
|
|
AGN
50
DELISTED
Allergan plc
AGN
| $116M | 0.34% | 389,070 +115,457 | +42% | +$34.4M |
|